We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biobots Advance Soft Biological Machines

By LabMedica International staff writers
Posted on 13 Jul 2014
Print article
Image: Tiny walking “bio-bots” are powered by muscle cells and controlled by an electric field (Photo courtesy of Janet Sinn-Hanlon, Design Group@VetMed).
Image: Tiny walking “bio-bots” are powered by muscle cells and controlled by an electric field (Photo courtesy of Janet Sinn-Hanlon, Design Group@VetMed).
A new generation of walking “biobots” powered by muscle cells and controlled with electrical pulses are providing researchers with never-before attained control over their function.

The engineers published their research in the online June 30, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). “Biological actuation driven by cells is a fundamental need for any kind of biological machine you want to build,” said study leader Rashid Bashir, a professor and head of bioengineering at the University of Illinois at Urbana-Champaign (U of I; USA). “We’re trying to integrate these principles of engineering with biology in a way that can be used to design and develop biological machines and systems for environmental and medical applications. Biology is tremendously powerful, and if we can somehow learn to harness its advantages for useful applications, it could bring about a lot of great things.”

Prof. Bashir’s group has been innovators in designing and constructing bio-bots, less than 1 cm in size, made of flexible three-dimensional (3D)-printed hydrogels and living cells. Earlier, the engineers demonstrated biobots that “walk” on their own, powered by beating heart cells from lab rodents. However, heart cells continually contract, denying researchers control over the bot’s motion. This makes it difficult to use heart cells to engineer a biobot that can be turned on and off, sped up or slowed down.

The new biobots are powered by a band of skeletal muscle cells that can be triggered by an electric pulse. This gives the researchers a simple way to control the biobots and creates an avenue for other cutting-edge design ideas, so engineers can tailor biobots for specific applications. “Skeletal muscles cells are very attractive because you can pace them using external signals,” Prof. Bashir said. “For example, you would use skeletal muscle when designing a device that you wanted to start functioning when it senses a chemical or when it received a certain signal. To us, it’s part of a design toolbox. We want to have different options that could be used by engineers to design these things.”

The design is engineered similar to the muscle-tendon-bone complex found in nature. There is a support of 3D-printed hydrogel, strong enough to give the biobot structure but flexible enough to bend like a joint. Two posts serve to fasten a strip of muscle to the backbone, similar in the way tendons attach muscle to bone, but the posts also act as feet for the biobot. A bot’s speed can be controlled by adjusting the frequency of the electric pulses. A higher frequency causes the muscle to contract faster, thereby speeding up the biobot’s progress as seen in the video (below).

“It's only natural that we would start from a biomimetic design principle, such as the native organization of the musculoskeletal system, as a jumping-off point,” said graduate student Caroline Cvetkovic, co-first author of the paper. “This work represents an important first step in the development and control of biological machines that can be stimulated, trained, or programmed to do work. It's exciting to think that this system could eventually evolve into a generation of biological machines that could aid in drug delivery, surgical robotics, 'smart' implants, or mobile environmental analyzers, among countless other applications.”

Next, the researchers will work to gain even greater control over the biobots’ motion, such as integrating neurons so the biobots can be directed in different directions with light or chemical gradients. On the engineering side, they hope to design a hydrogel backbone that allows the biobot to move in different directions based on different signals. Due to 3D printing technology, engineers can examine different shapes and designs quickly. Prof. Bashir and colleagues even plan to integrate a unit into undergraduate lab curriculum so that students can design different kinds of biobots.

“The goal of ‘building with biology’ is not a new one--tissue engineering researchers have been working for many years to reverse engineer native tissue and organs, and this is very promising for medical applications,” said graduate student Ritu Raman, co-first author of the study. “But why stop there? We can go beyond this by using the dynamic abilities of cells to self-organize and respond to environmental cues to forward engineer non-natural biological machines and systems.”

“The idea of doing forward engineering with these cell-based structures is very exciting,” Prof. Bashir commented. “Our goal is for these devices to be used as autonomous sensors. We want it to sense a specific chemical and move towards it, then release agents to neutralize the toxin, for example. Being in control of the actuation is a big step forward toward that goal.”

Related Links:

University of Illinois at Urbana-Champaign


New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Rickettsia Conorii Assay
RICKETTSIA CONORII ELISA

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.